Root Financial Partners’s Kura Oncology KURA Stock Holding History

Root Financial Partners’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-318	Closed	-$2.58K	–	1919
2026 Q1	$2.58K	Buy	+318	New	+$2.73K	﹤0.01%	2206

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Root Financial Partners's KURA Position: Q2 2026 in Review

Root Financial Partners sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 318 shares — an estimated $2.58K sold.

Root Financial Partners first reported a position in KURA in Q1 2026 and held it in 1 quarter. The position peaked at $2.58K in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Root Financial Partners reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 318 Kura Oncology shares in Q2 2026, an estimated $2.58K.
Root Financial Partners first reported a position in Kura Oncology in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Kura Oncology position peaked at $2.58K in Q1 2026.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.